Left atrial enlargement (LAE) has adverse prognostic implications in hypertension. We sought to determine the accuracy of five electrocardiogram (ECG) criteria for LAE in hypertension relative to cardiac magnetic resonance (CMR) gold standard and investigate the effect of concomitant obesity. One hundred and thirty consecutive patients (age: 51.4 ± 15.1 years, 47% male, 51% obese, systolic blood pressure (BP): 171 ± 29 mm Hg, diastolic BP: 97 ± 15 mm Hg) referred for CMR (1.5 T) from a tertiary hypertension clinic were included. Patients with concomitant cardiac pathology were excluded. ECGs were assessed blindly for the following: (1) P-wave 4110 ms, (2) P-mitrale, (3) P-wave axis o 30°, (4) area of negative P-terminal force in V1 440 ms.mm and (5) positive P-terminal force in augmented vector left (aVL) 40.5 mm. Left atrial volume ≥ 55 ml m − 2 , measured blindly by CMR, was defined as LAE. Sensitivity, specificity, positive predictive value, negative predictive value, accuracy and area under the receiver operator curve were calculated. The prevalence of LAE by CMR was 26%. All the individual ECG LAE criteria were more specific than sensitive, with specificities ranging from 70% (P-axis o 30 o ) to 99% (P-mitrale). Obesity attenuated the specificity of most of the individual ECG LAE criteria. Obesity correlated with significant lower specificity (48% vs 65%, P o 0.05) and a trend towards lower sensitivity (59 vs 43%, P = 0.119) when ≥ 1 ECG LAE criteria were present. Individual ECG criteria of LAE in hypertension are specific, but not sensitive, at identifying LAE. The ECG should not be used to excluded LAE in hypertension, particularly in obese subjects.
INTRODUCTION
The 2013 Joint European Society of Cardiology and European Society of Hypertension guidelines for the management of arterial hypertension advise that a 12-lead electrocardiogram (ECG) should be acquired for all patients with hypertension. 1 The ECG can show evidence of left atrial enlargement (LAE), which is an important predictor of cardiovascular mortality and morbidity. Indeed, performing an ECG in all subjects with hypertension is advised by the American Society of Hypertension and International Society of Hypertension in their joint clinical practice guidelines, at least in part to assess for LAE. 2 LAE has been demonstrated to be a marker of left ventricular (LV) diastolic dysfunction 3 and a predictor of the development of atrial fibrillation, 4 congestive heart failure, 5 stroke, 6 myocardial infarction 7 and cardiac mortality. 8 Detecting LAE is therefore important in subjects with hypertension. LAE can be demonstrated on ECG. The first line imaging modality to structurally assess the heart in hypertension is the echocardiogram and this can be used to gauge the left atrial (LA) size. To date, LAE ECG criteria have been assessed against two-dimensional (2D) echocardiography reference standards [9] [10] [11] [12] . However, echocardiographic measurements may be inaccurate due to limited acoustic windows and variation in image acquisition planes. This may be particularly troublesome in obesity subjects, with is a common comorbidity in subjects with hypertension. Furthermore, since the LA is not spherical, the assumption of a constant radius necessary for the M-mode or some 2D echocardiography measurements, for example, the ellipsoid method, does not hold true, limiting the accuracy. 13 Cardiac magnetic resonance (CMR) imaging has superior spatial resolution compared with echocardiography and can consistently acquire LA images regardless of patient body habitus and, for these reasons, CMR is considered the gold standard for atrial assessment. Yet, there are few studies investigating the diagnostic performance of ECG LAE criteria against CMR. Furthermore, those existing studies were either in unselected subjects undergoing CMR and not in the context of hypertension 14 or have used an indexed LA volume of 428 ml m − 2 to define LAE, 15 which is from the echocardiogram literature, 16 and is significantly lower than LA volume of 55 ml m − 2 , which is 2 standard deviation measurements above the mean of normal, healthy subjects from published CMR studies. [17] [18] [19] [20] Thus, to date, ECG LAE criteria appear to have been validated against a variety of reference standards. As the ECG is often the first diagnostic investigation performed when assessing for LAE in hypertensive patients and treatment decisions may be made on its results, understanding the diagnostic performance of the ECG at detecting LAE relative to CMR gold standard in a cohort of hypertensive subjects is important.
Obesity and hypertension are common co-morbidities. The former has also been associated with LAE. 21 However, to the best of our knowledge, no previous study has investigated the impact of obesity on the diagnostic performance of the ECG at detecting LAE. Consequently, our aim was to comprehensively evaluate the diagnostic performance of five ECG criteria for the detection of LAE, in a cohort of hypertensive patients with high LAE prevalence, relative to CMR-derived measurements of LA volume. In addition, we sought to determine the effect of obesity on the diagnostic performance of the ECG at detecting LAE.
SUBJECTS AND METHODS

Study population
In our institution, CMR is used routinely in the tertiary hypertension clinic setting to detect hypertensive end-organ damage and screen for potential secondary causes of hypertension. 22 In this study, we included all eligible, consecutive hypertensive patients referred for a CMR from the Bristol Heart Institute tertiary hypertension clinic, which has a catchment area of the South West of England, between January 2011 and February 2015 ( Figure 1 ). Subjects were excluded from analysis if they exhibited any concomitant cardiac pathology, which could confound the aetiology of LAE, such as previous myocardial infarction, other cardiomyopathy and/or moderate-severe valvular heart disease.
Demographic and baseline clinical data were documented. The World Health Organization definition of obesity of body mass index (BMI) 430 kg m − 2 was used. 23 The mean office systolic blood pressure (BP) and diastolic BP values were from repeated readings from both arms, where available, recorded with an appropriately sized BP cuff at the time of ECG acquisition, following a period of 5 min seated rest.
Subjects provided written consent for their images to be used for research.
The study conformed to the governance arrangements for research ethics committees.
Electrocardiogram
A standard 12-lead ECG (scale: 10 mm = 1 mV, speed: 25 mm s − 1 ) was recorded supine, during quiet respiration. The analysing clinician was blinded to all other CMR and clinical data. The presence of complete bundle branch block was an exclusion criterion. The five ECG LAE criteria evaluated were: (1) P-wave 4110 ms, (2) P-mitrale (notched P-wave with inter-peak duration 440 ms), (3) P-wave axis o 30°, (4) area of negative P-terminal force in lead V1 (NPTF-V1)440 ms.mm and (5) positive P-terminal force in augmented vector left (aVL) (PPTF-aVL) 40.5 mm. 9, 12, 24, 25 CMR protocol CMR was performed with the subjects lying supine at 1.5 T (Avanto, Siemens, Erlangen, Germany), with anterior eight-element and posterior eight-element body-array coils. Steady-state free precession (SSFP) cines were acquired (time to echo 1.07 ms, temporal resolution 38.1 ms, in-plane pixel size 2.0 × 2.0 mm and matrix 156 × 192) with retrospective ECG gating and breath holding. The entire LV was imaged with short axis SSFP with slice thickness of 8 mm and no slice gap. The standard three long-axis cines (four-chamber, two-chamber and three-chamber views) were acquired at 60°from each other. In addition, late gadolinium myocardial enhancement imaging was routinely acquired using an inversion-recovery fast gradient echo sequence, as well as a phase-sensitive inversionrecovery sequence, 10-15 min following 0.1 mmol per kg intravenous gadobutrol (Gadovist, Bayer Pharma AG, Leverkusen, Germany). Inversion times were optimized in each patient to ensure adequate nulling of normal myocardium. Subjects with subendocardial late gadolinium myocardial enhancement consistent with previous myocardial infarction were excluded.
CMR analysis
All CMR analysis was performed blinded to all other clinical and ECG data by an experienced CMR reader using dedicated CMR postprocessing software (CMR42, Circle Cardiovascular Imaging Inc., Calgary, Canada). Maximum LA volume was measured at maximal atrial dilatation at LV end systole, as previously described ( Figure 2 ). 14, 26 Briefly, maximum LA volume was defined as the image immediately preceding the opening of the mitral valves on SSFP cines. LA length was measured at maximum atrial dilatation from the posterior LA wall to the level of the mitral valve plane, parallel to the long axis of the heart, in the two-chamber and four-chamber SSFP cines. The endocardial board of the LA was manually contoured at maximum atrial diastole in the apical two-chamber and four-chamber SSFP cines. The confluence of the pulmonary veins and LA appendage were excluded from planimetry measurements. The LA borders were delimited at the planes of the atrio-ventricular annulus and the junctions of venous inflow. LA volume was then calculated according to the biplane arealength method and then indexed to body surface area, 16 ,27,28 calculated using the Mosteller formula. LAE was defined as ≥ 55 ml m − 2 , which is 2 standard deviation measurements above the mean of normal, healthy subjects from published CMR studies. [17] [18] [19] [20] Left ventricular (LV) mass was measured as described previously. 29, 30 In brief, LV endocardial contours were generated on the short axis SSFP cines stack at end diastole using previously validated 31 blood-pool threshold detection software (CMR42, Circle Cardiovascular Imaging Inc.). Epicardial contours were manually plotted. LV mass was derived by multiplying total myocardial volume, inclusive of trabeculae and papillary muscles, by myocardial specific gravity (1.05 g ml − 1 ), as previously described. 29 LV mass was indexed to body surface area. LV hypertrophy (LVH) was defined as LV mass/body surface area 495th percentile of established CMR reference ranges (women = 77-78 g m − 2 and men = 89-93 g m
). 29 
Statistical analysis
All statistical analyses were performed in SPSS (v.21; IBM Corp., Armonk, NY, USA). Using the pooled prevalence of LAE of 32% from a recent systematic review of 10 141 subjects assessed by echocardiogram, 32 an α-error of 0.05 and a statistical power of 90%, the sample size for our study, accounting for the fact that CMR has been demonstrated to reduce the sample sizes by sixfold compared with 2D echocardiogram when a power of 90% is employed 33 , should be 100. Consequently, our final sample size of 130 subjects, from an initial 160 subjects who were screened, was sufficient for this study. Normally distributed continuous variables were expressed as mean ± s.d. and compared using unpaired Student's t-test or one-way analysis of variance with post-hoc correction for multiple testing as appropriate. Categorical variables were expressed as percentages and interrogated with the Fisher's exact test. Specificity, sensitivity, negative predictive value, positive predictive value and accuracy were also calculated. Area under the receiver-operating curve analysis was performed and to compare the diagnostic performance of the various ECG criteria. R-values are for Pearson's correlation coefficient. Multivariate logistic regression analysis was performed to identify Figure 1 . A flow chart demonstrating the study exclusion criteria and final sample size (n = 130). *Image artefact from implantable loop recorder device precluding volumetric assessment from LV short axis SSFP cine stack. AVR, aortic valve replacement; CMR, cardiac magnetic resonance; DCM, idiopathic dilated cardiomyopathy (CMR diagnosis); HOCM, hypertrophic obstructive cardiomyopathy (clinical and/or CMR diagnosis); LVNC, left ventricular non-compaction cardiomyopathy (CMR diagnosis); MI, myocardial infarction (defined as subendocardial late gadolinium enhancement on CMR); Mod AR, moderate aortic regurgitation.
independent predictors of ECG false positives and false negatives of LAE relative to CMR. Statistical significant was set at Po0.05.
RESULTS
Demographics
One hundred and sixty consecutive patients referred for CMR were assessed for eligibility. Thirty patients met the exclusion criteria (Figure 1 ), resulting in a final sample size of 130 (men: 47%, age: 51 ± 15 years). CMR evidence of LAE was present in 26% (n = 34) and obesity was present in 51% (n = 67) of the cohort. There were no significant differences between non-obese and obese cohorts for the following variables: age, gender, office systolic BP, office diastolic BP, treatment with angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker or calcium channel blocker (Table 1) .
Diagnostic performance of ECG criteria of LAE Specificity was higher than sensitivity for all ECG LAE criteria ( Table 2) . Specificities ranged from 70 to 99% for the individual ECG criteria of LAE. However, the sensitivities ranged from 0 to 18% and the best performance on area under the receiveroperating curve was 0.502 (95th confidence interval: 0.389-0.616) for PPTF-aVL40.5 mm. A composite ECG criterion consisting of any positive individual ECG criteria for LAE had the highest sensitivity of 29% but a specificity of 48% and accuracy of 43%.
Obesity subgroup analysis of diagnostic performance of ECG criteria for LAE The specificity was significantly lower in obese subjects compared with non-obese subjects for P-wave o30°(non-obese: 83% vs obese: 64%, Po0.05) and for the composite ECG criterion consisting of any positive individual ECG criteria (non-obese: 65% vs obese: 48%, Po0.05; Table 3 ). There were nonsignificant trends for lower specificity for NPTF-V1440 ms.mm (non-obese: 89% vs obese: 78%, P = 0.06) and PPTF-aVL40.5 mm (non-obese: 96% vs obese: 88%, P = 0.07) for obese compared with non-obese subjects.
The area under the receiver-operating curve values were lower for all ECG criteria of LAE and for the composite ECG criterion consisting of any positive individual ECG criteria for obese subjects compared with non-obese subjects (Table 3) .
Indexed LA size in subjects with positive ECG criteria The mean indexed LAV was not significantly different between those subjects with positive ECGs compared with negative ECGs for all the ECG criteria for LAE investigated (Table 4 ). There was no correlation between the number of positive ECG criteria and absolute LAV (R = − 0.05, P = 0.66) or index LAV (R = − 0.09, P = 0.4). However, in obesity subgroup analysis, there were consistent trends towards larger absolute and indexed LAV in obese subjects who did not fulfill ECG criteria for LAE compared with obese subjects who did fulfill ECG criteria for LAE. In addition, obese subjects who did not fulfill ECG criteria for LAE had significantly larger absolute LAV compared with similar non-obese subjects but these significant differences no longer persisted after indexing the LAV to body surface area.
Prevalence of LAE in subjects without hypertensive LVH Of the 130 hypertensive subjects, 35% (46/130) had LVH and 65% (84/130) did not have LVH. LAE occurred in 19% (16/84) of subjects without LVH. However, the prevalence of LAE among subjects with LVH (39%, 18/46) was significantly higher than among subjects without LVH (LAE and LVH: 39% vs LAE and no LVH: 19%, P o0.05).
Predictors of false-positive ECG criteria for LAE Multivariate logistic regression analyses, accounting for age, gender and BMI, were performed to identify predictors of false-positive and false-negative ECGs for LAE (Table 5 ). For P-wave axis o30°, female gender and increasing BMI were significant independent predictors of false-positive ECGs for LAE relative to CMR gold standard. Age, gender and BMI were not predictors of false-negative ECGs for LAE.
DISCUSSION
For the first time, we investigate the impact of obesity on the diagnostic performance of the ECG at detecting LAE as compared with CMR gold standard in subjects with arterial hypertension.
We demonstrate that all the ECG criteria for LAE are poor at excluding LAE relative to CMR. Consequently, a normal ECG in a hypertensive patient has a high chance of being falsely reassuring for an absence of LAE and is less specific for LAE in the presence of obesity. LAE is a marker of LV diastolic dysfunction 3 and a predictor for the development of atrial fibrillation, 4 congestive heart failure, 5 stroke, 6 myocardial infarction 7 and cardiac mortality. 8 Failing to identify LAE may alter an individual's cardiovascular risk estimation and theoretically could have treatment implications. 1 Furthermore, in subgroup analysis of the LIFE study, Wachtell et al. 34 found that prevention of atrial fibrillation during antihypertensive treatment may be improved by antihypertensive therapy that reduces LA size in addition to controlling BP and the effect of different antihypertensive agents on LA size has previously been investigated. 35 The sensitivity of the ECG at excluding LAE has varied from 6 to 69% relative to echocardiography in previous studies. [9] [10] [11] [12] 36 Regarding individual ECG criteria, we found higher sensitivity for P-wave 4110 ms compared with previous echocardiographic studies. 9, 10, 12, 25 We demonstrate higher sensitivity for P-mitrale and NPTF-V1440 ms. mm compared with the most recent echocardiographic study of 261 randomly selected patients, which calculated LAV using a similar bi-plane atrial volume analysis from 2D echocardiography. 36 Our findings are similar to those of Tsao et al.
14 who performed ECG-CMR correlation, albeit in unselected patients.
However, it should be realized that a direct comparison between existing echocardiography studies and our work is prone to discrepancy. Estimation of atrial size with echocardiography, both by M-mode and 2D techniques, may be limited by poor acoustic windows and limited spatial resolution, which may underestimate LA dimensions. Indeed, the atrial size measured by CMR measurement are recognized to exceed echocardiograph measurements of LAV by 14-37%. 37, 38 As a result, the thresholds and accuracy for defining LAE will differ between studies using CMR and echocardiography as the gold standard for LAV and, therefore, the proportion of individuals classified as having LAE will also differ, which will have an impact on sensitivity and specificity analyses. Furthermore, differing allometric scaling of LAV between studies may be another important variable.
Although the ECG criteria generally have a high specificity for identifying LAE, we show for the first time that the diagnostic performance falls in the presence of obesity. This is potentially an important finding with clinical implications. The MONIC/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study of 1 212 participants demonstrated that although both hypertension and obesity were predictors of LAE, obesity was numerically stronger. 39 Furthermore, obese hypertensive Abbreviations: ACC, accuracy; CI, confidence interval; ECG, electrocardiogram; LA, left atrial; LAE, left atrial enlargement; NPV, negative predictive value; PPV, positive predictive value; PPTF-aVL, positive P-terminal force in aVL; ROC-AUC, receiver operator curve-area under curve.
subjects had the largest indexed LAV. 39 The lower specificity of the ECG at identifying LAE relative to CMR in our study in obese subjects compared to non-obese subjects means that the ECG risks missing LAE in subjects who are at a particular high risk for LAE. A putative reason why the ECG is less able to detect enlarged atria in obese subjects is due to electrical insulating effects of excess subcutaneous adipose tissue, a phenomenon which has previously been postulated to explain the effect of obesity on reducing the diagnostic performance of the ECG at detecting LVH. 40, 41 Imaging obese hypertensive subjects with echocardiography to establish a diagnosis of LAE may also be difficult, because adipose tissue can attenuate the ultrasonic beam and reduce the diagnostic quality of the study.
In terms of the clinical implications of our study, we suggest that the ECG should still remain the initial investigation of choice for assessing for LAE as advised in International guidelines. 1, 2 However, clinicians should take into account the patient's BMI when interrogating the ECG for LAE. For example, we show that the positive predictive value is significantly lower in obese hypertensive subjects compared with non-obese subjects for P-axiso 30 o and PPTF-aVL40.5 mm. The sensitivity of the investigation is also poor for both obese and non-obese subjects. It is clearly not practicable to perform CMR in all subjects with hypertension. Clinicians should consider investigating hypertensive patients with an additional modality, such as echocardiography in the first instance, to confirm the presence of LAE in obese subjects with positive P-axis o 30°and PPTF-aVL40.5 mm criteria, and in subjects where exclusion of LAE is important and may have therapeutic implications, for example, in subjects with no other evidence of end-target damage where the demonstration of LAE would alter the cardiovascular risk sufficiently to alter treatment. 1 Finally, it is important to recognize that abnormalities in atrial conduction and hence the electric signal recorded from the atria on the ECG in the form of the P-wave can be independent of atrial size. 42, 43 Multiple aetiologies may manifest with similar P-wave abnormalities on ECG. As a result, in unselected populations, the ECG is unlikely to have good specificity for LAE as the changes may simply represent atrial abnormality rather than enlargement.
Limitations
Our clinical cohort study had a modest sample size of 130 patients. However, the increased accuracy and reproducibility of CMR relative to echocardiography increases the statistical power of the study. Furthermore, our study was in a selected population of wellcharacterized hypertensive subjects and excluded patients with other concomitant cardiac pathology. Consequently, our results are more applicable to the hypertension community than most of the previous studies that have been in unselected populations.
We do not routinely estimate total body fat mass in our clinical practice and this variable could not be investigated. BMI has been used as a routinely recorded clinical surrogate. Theoretically, an increase in lean muscle mass could yield a BMI value in the obesity range but this is unlikely to have occurred in our cohort of patients.
In this non-invasive study, we were unable to adjust for certain variables that may alter P-wave morphology, for example, atrial pressure. 43 The diagnostic accuracy of the ECG at detecting LVH in hypertension was not investigated in this study, but has been recently described. 30 
CONCLUSION
We have recalibrated five ECG criteria for LAE against current non-invasive gold-standard CMR. The individual ECG criteria are more specific than sensitive at identifying anatomical LAE relative to CMR. However, the concomitant presence of obesity reduces the specificity for most ECG criteria for LAE. Clinicians need to be aware of these differences when interpreting the European Society of Cardiology/European Society of Hypertension and American Society of Hypertension and International Society of Hypertension guidelines, and tailor the ECG criteria they use accordingly taking into account the patient's BMI. Although the ECG may identify LAE, it has poor sensitivity and therefore the ECG should not be used in isolation to exclude LAE where this could have treatment implications.
Obese hypertensive subjects are at risk of false-positive and false-negative results if the ECG is used to screen of LAE.
What is known about this topic?
• Detecting LAE in hypertension has prognostic and treatment implications.
• The ECG can detect LAE and it has been validated against echocardiographic assessment of LA size.
• The impact of obesity on the ECG detection of LAE has not previously been investigated.
What this study adds?
• We recalibrate five ECG criteria for LAE against non-invasive goldstandard CMR.
• We show the ECG is more specific than sensitive at detecting LAE, and that obesity reduces ECG specificity at detecting LAE.
• We identify predictors of false-positive and false-negative ECG results with multivariate logistic regression analysis.
• In hypertension, the ECG should not be used to exclude LAE.
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